2nd Quarter - Report

GILEAD SCIENCES, INC. for GILEAD SCIENCES INC

Period 2nd Quarter 2009 Filed Jul 20, 2009 Signed by Cristin Lis

Official filing
Firm
GILEAD SCIENCES, INC.
Client
GILEAD SCIENCES INC
Income
—
Expenses
$290,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

International Trade Issues; Global Health Issues; FDA Globalization Act; Domestic HIV Policy Issues (eg. H.R. 1429-Stop AIDS in Prison Act; H.R. 2137 - Routine HIV/AIDS Screening Coverage Act; Ryan White Program Reauthorization Act.); Sunshine Act.

LobbyistCovered position, as disclosed
CRISTIN LIS —

Contacted: U.S. Trade Representative (USTR); Commerce, Dept of (DOC); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); State, Dept of (DOS)

Bills named: H.R. 2137 (111th), H.R. 1429 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.